EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyaluronic acid and PEA-based Rutin-loaded nanoparticles as new cardioprotective tool against anthracycline-induced cardiotoxicity

Carla Serri, Vincenzo Quagliariello, Massimiliano Pio di Cagno, Paolo Giunchedi, Giovanna Rassu, Nicola Maurea, Elisabetta Gavini

European Journal of Pharmaceutics and Biopharmaceutics · 2026

DOI: 10.1016/j.ejpb.2026.115165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Carla Serri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Pharmacy, University of Sassari, via Muroni 23/A, 07100 Sassari, Italy. Electronic address: cserri@uniss.it. Hauptthemen laut MEDLINE: Hyaluronic Acid, Rutin, Nanoparticles, Cardiotoxicity. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Banco di Sardegna, Autonomous Region of Sardinia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A dual cardioprotective strategy was developed using lipid-polymer hybrid nanoparticles co-encapsulating rutin and palmitoylethanolamide (PEA), with or without hyaluronic acid (HA). This approach may enhance cardioprotection by improving the delivery of rutin, an agent with strong antioxidant and anti-inflammatory effects whose clinical application is constrained by poor solubility and low bioavailability. PEA, known for modulating the endocannabinoid system and inhibiting NLRP3 inflammasome activation, offers a complementary mechanism to reduce inflammation and oxidative stress. The LPNs were prepared via nanoprecipitation technique. The LPNs lacking HA exhibited an average size ∼171 nm, while HA-based LPNs displayed larger sizes ∼247 nm, accompanied by negative zeta potentials (from -20.13 to -29.95 mV) and surface hydrophilicity attributable to HA. Despite these variations, drug content and encapsulation efficiencies remained comparable between formulations. In vitro release and permeation (PermeaPad®) experiments demonstrated formulation-dependent differences in rutin delivery. Notably, HA and PEA-based LPNs significantly protected cardiomyocytes from DOXO toxicity, evidenced by decreased apoptosis, caspase activation, and LDH release, while upregulating protective proteins (Nrf2, SIRT1) and downregulating inflammatory mediators (NLRP3, MyD88, IL-1β, IL-6). These findings support the potential of HA and PEA-based LPNs as a targeted strategy to preserve anticancer efficacy while reducing DOXO-associated cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidRutinNanoparticlesCardiotoxicityCardiotonic AgentsAnimalsDoxorubicinAmidesOxidative StressMyocytes, CardiacDrug CarriersAntioxidantsHumansApoptosisDrug LiberationParticle SizeEthanolaminesPalmitic Acids

Stichwörter der Autor:innen

CardiotoxicityDoxorubicinHyaluronic acidHybrid nanoparticlesOxidative stressPalmitoylethanolamideRutin

Substanzen

Hyaluronic AcidRutinDoxorubicinAmidespalmidrolCardiotonic AgentsDrug CarriersAntioxidantsEthanolaminesPalmitic Acids

Autor:innen und Institutionen

  • Department of Medicine, Surgery and Pharmacy, University of Sassari, via Muroni 23/A, 07100 Sassari, Italy. Electronic address: cserri@uniss.it.
  • Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy. Electronic address: v.quagliariello@istitutotumori.na.it.
  • Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via L. Giorgieri 1, 34127 Trieste, Italy; Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Sem Saelands…
  • Department of Medicine, Surgery and Pharmacy, University of Sassari, via Muroni 23/A, 07100 Sassari, Italy. Electronic address: pgiunc@uniss.it.
  • Department of Medicine, Surgery and Pharmacy, University of Sassari, via Muroni 23/A, 07100 Sassari, Italy. Electronic address: grassu@uniss.it.
  • Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy. Electronic address: n.maurea@istitutotumori.na.it.

Förderung

  • Fondazione Banco di Sardegna
  • Autonomous Region of Sardinia

Zitieren

APA

Serri, C., Quagliariello, V., Pio di Cagno, M., Giunchedi, P., Rassu, G., Maurea, N., & Gavini, E. (2026). Hyaluronic acid and PEA-based Rutin-loaded nanoparticles as new cardioprotective tool against anthracycline-induced cardiotoxicity. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115165

Vancouver

Serri C, Quagliariello V, Pio di Cagno M, Giunchedi P, Rassu G, Maurea N, et al. Hyaluronic acid and PEA-based Rutin-loaded nanoparticles as new cardioprotective tool against anthracycline-induced cardiotoxicity. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115165

BibTeX
@article{Serri2026,
  author = {Serri, Carla and Quagliariello, Vincenzo and Pio di Cagno, Massimiliano and Giunchedi, Paolo and Rassu, Giovanna and Maurea, Nicola and Gavini, Elisabetta},
  title = {Hyaluronic acid and PEA-based Rutin-loaded nanoparticles as new cardioprotective tool against anthracycline-induced cardiotoxicity},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  doi = {10.1016/j.ejpb.2026.115165}
}
Kostenlos starten →